CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company has initiated a process to evaluate ...

Dentsply Sirona initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business. Wellspect, a provider of bladder and bowel management care products, has an estimated $2 ...

Dentsply Sirona announced that it initiated a process to evaluate strategic alternatives for its Wellspect Healthcare ...

Extends Private Placement and Grants Stock Options Toronto, Ontario--(Newsfile Corp. - February 12, 2025) - City View Green ...

Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that the Veradigm Board of Directors (the “ ...

FORT WORTH, Texas - PharmChem, Inc. (OTC: PCHM), known for its drug-detecting sweat patches and currently trading at $3.07 near its 52-week low, announced Monday that its Board of Directors is ...

The company's management and Board of Directors are now exploring strategic alternatives to maximize shareholder value, which may include potential acquisitions or business combinations.

There is no deadline or definitive timetable set for completion of the strategic alternatives review process and there can be no assurance that this process will result in the Company pursuing a ...

DENTSPLY SIRONA (XRAY) has initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business. Wellspect is a leading ...